ClinicalTrials.Veeva

Menu

Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix (MIRO)

M

Motiva

Status

Completed

Conditions

Breast Augmentation

Treatments

Other: MRI and PRO

Study type

Observational

Funder types

Industry

Identifiers

NCT05449587
CLINP- 001010

Details and patient eligibility

About

Post-marketing surveillance study to demonstrate the silent rupture rate and satisfaction of patients who underwent a primary and revision breast augmentation surgery with Motiva Implants®, 3 to 10 years before enrollment.

Full description

Single-arm, multicenter study with a minimum of 160 subjects who underwent Breast Implant surgery from 3-10 years postoperatively.

Following IRB / EC approval - and if applicable Competent Authority approval - Magnetic Resonance Imaging (MRI) and Patient-Reported Outcome (PRO) with the validated BREAST-Q will be collected at a single time point for all enrolled subjects.

MRI data will be used for the analysis of silent rupture, and BREAST-Q Postoperative Augmentation module scales to record patients for satisfaction.

Two styles of Motiva Implants® will be used for this study:

  • Motiva Implants® Silicone Gel-Filled Breast Implants, SmoothSilk® Round (referred to as "Motiva Implants® Round ProgressiveGel® Plus", or "Round")
  • Motiva Implants® Silicone Gel-Filled Breast Implants, SmoothSilk® Round Ergonomix® (referred to as "Motiva Implants® Ergonomix® Round ProgressiveGel® Ultima®", or "Round Ergonomix").

Henceforth, these devices will generally be referenced as "Motiva Implants®."

Enrollment

111 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Cisgender women.
  • The subject has undergone primary or revision augmentation surgery with Motiva Implants® Round or Round Ergonomix®, which are still implanted before enrolling in the study.
  • The subject underwent breast implant surgery at least three (3) years or more before enrolling in the study.
  • The subject has undergone an MRI to evaluate implant rupture in the last 3 years before enrolling in the study or is willing to undergo an MRI evaluation.
  • The subject is willing to follow all study requirements (signing informed consent, completing questionnaires, attending a baseline visit, and allowing access to previous MRI images or having new MRI images for the study).

Exclusion criteria

  • The subject had undergone fat grafting, needle biopsy, or any procedures that might have caused an iatrogenic rupture.
  • The Subject or Investigator are aware of a possible ruptured device that has not been removed.
  • The subject is pregnant or nursing.
  • The subject has any condition that impedes the use of Magnetic Resonance Imaging (MRI), including implanted metal devices, claustrophobia, or other conditions that would prohibit MRI scans.

Trial design

111 participants in 1 patient group

Primary /Revision Augmentation Cohort
Description:
Patients that underwent primary and/or revision augmentation from 3 years or more postoperatively.
Treatment:
Other: MRI and PRO

Trial contacts and locations

2

Loading...

Central trial contact

Ana Vega, MD; Sofia Chaves, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems